42 results on '"Caskey S"'
Search Results
2. 212 Body mass index changes over time and after initiation of a cystic fibrosis transmembrane conductance regulator modulator in a population with cystic fibrosis
3. Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
4. First do no harm: changing culture surrounding ceilings of treatment in end-of-life care
5. P077 Clinical factors affecting timing of referral for lung transplantation for people with cystic fibrosis: a national comparison of opinions between adult cystic fibrosis and transplant centres
6. P039 The clinical impact of triple CFTR modulator therapy in a cohort of people with cystic fibrosis and severe lung disease
7. P128 A reviewof inhaled corticosteroid prescribing in an adult cystic fibrosis population
8. P149 A review of the clinical trajectory of adults with cystic fibrosis prescribed nebulised Aztreonam Lysine (Cayston™)
9. P304 A questionnaire to assess views, practices and barriers to physical activity in adults with cystic fibrosis
10. WS03.3 A review of ursodeoxycholic acid prescribing in an adult cystic fibrosis population
11. P353 “There’s no place like home”: formalising the provision of home IV antibiotics for people with cystic fibrosis in Northern Ireland
12. P197 The effect of ivacaftor on clinical trajectory of adults with cystic fibrosis carrying a R117H mutation
13. Hybrid triad provides fracture plane stability in a computational model of a Pauwels Type III hip fracture
14. P100 Prevalence of chronic Pseudomonas aeruginosa infection in people with cystic fibrosis in Northern Ireland
15. P170 Bacterial and fungal co-colonisation leads to poorer clinical outcomes in an adult cystic fibrosis population
16. P453 An eight-year retrospective audit of clinical psychology referrals within the Northern Ireland Regional Adult Cystic Fibrosis Centre
17. P206 Does adherence to DNase change following initiation of Orkambi for the treatment of cystic fibrosis?
18. P112 Proton pump inhibitor use is associated with increased pulmonary exacerbations and hospital admissions in adult patients with cystic fibrosis
19. P127 The role of the specialist cystic fibrosis pharmacist in embedding adherence monitoring of inhaled therapies into clinical care
20. P162 The relationship of Cystic Fibrosis-Related Diabetes (CFRD) and abnormal lipid profiles in adults with cystic fibrosis
21. P191 Gender differences in lipid profiles in adults with cystic fibrosis
22. Occurrence ofPseudomonas aeruginosain waters: implications for patients with cystic fibrosis (CF)
23. Belfast Agar–a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF)
24. Occurrence of Pseudomonas aeruginosa in taps: implications for patients with cystic fibrosis
25. P93 In- vitro activity of seven hospital biocides against mycobacterium abscessus
26. Occurrence of <italic>Pseudomonas aeruginosa</italic> in waters: implications for patients with cystic fibrosis (CF).
27. Low-temperature thermochronology of the Black and Panamint mountains, Death Valley, California: Implications for geodynamic controls on Cenozoic intraplate strain
28. Belfast Agar-a simple laboratory medium to separate <italic>Pseudomonas aeruginosa</italic> from pan-resistant <italic>Burkholderia cenocepacia</italic> isolated from the sputum of patients with cystic fibrosis (CF).
29. Using Surface Creep Rate to Infer Fraction Locked for Sections of the San Andreas Fault System in Northern California from Alignment Array and GPS Data.
30. Belfast Agar–a simple laboratory medium to separate Pseudomonas aeruginosafrom pan-resistant Burkholderia cenocepaciaisolated from the sputum of patients with cystic fibrosis (CF)
31. Computational Fluid Dynamics Simulations to Assess Spatial Variability and Optimal Ventilation Scenarios for Biological Laboratory Exposures.
32. Mind the gap!: Need for improved harmonization of antibiotic susceptibility testing of the nontuberculous mycobacteria between cystic fibrosis clinical guidelines and Mycobacterium antibiotic susceptibility testing laboratories.
33. Frontal Crash Injury Metrics Are Below Mandated Limits for a Spica Casted Child Dummy in Currently Available Restraints.
34. Injury metrics are altered in spica-casted versus non-casted child ATDs in side-impact collisions with door intrusion.
35. Who's at The Door? - Surface Contamination of Door Frames in a Single-Bedded In-Patient Adult Cystic Fibrosis (CF) Unit.
36. The Effect of Booster Seat Use on Pediatric Injuries in Motor Vehicle Frontal Crashes.
37. Case study: Fixture water use and drinking water quality in a new residential green building.
38. In vitro activity of seven hospital biocides against Mycobacterium abscessus : Implications for patients with cystic fibrosis.
39. Proteopedia entry: G-protein coupled receptors.
40. Structural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia.
41. Test-Retest Reliability of the Genetics and Genomics in Nursing Practice Survey Instrument.
42. Methods of genomic competency integration in practice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.